EUVIMEDOpdag EUVIMED
Video/Audio

RNA-seq Profiling of Draining and Metastatic Lymph Nodes in HER2-Positive Breast Cancer Identifies POSTN as a Prognostic Marker

Xiurong Zhang, Fei Xu, Jiehui Yang

Journal of Visualized Experiments · 2026

DOI: 10.3791/69570 ↗

At a glance

Video/Audio in Journal of Visualized Experiments, 2026. Written by Xiurong Zhang and 2 co-authors. Institution: Department of Breast Surgery, Boai Hospital of Zhongshan. Major MEDLINE topics: Breast Neoplasms, Erb-b2 Receptor Tyrosine Kinases, Biomarkers, Tumor, Lymph Nodes. 25 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

HER2-positive breast cancer is clinically aggressive and frequently disseminates to regional lymph nodes, yet the transcriptomic programs associated with nodal spread remain incompletely defined. Here, we profiled matched tumor-draining lymph nodes (TDLN) and metastatic tumor-involved lymph nodes (TMLN) from six patients with HER2-positive breast cancer using RNA sequencing (RNA-seq). Differential expression analysis was performed with DESeq2, applying Benjamini-Hochberg correction (FDR < 0.05) and an absolute log2 fold-change threshold (|log2FC| ≥ 1). We identified 237 differentially expressed genes (182 upregulated and 55 downregulated in TMLN vs. TDLN). Functional enrichment analyses highlighted extracellular matrix (ECM)-receptor interaction, PI3K-AKT signaling, focal adhesion, and cholesterol metabolism as prominent pathways associated with metastatic lymph nodes, suggesting coordinated ECM remodeling and signaling activation during nodal dissemination. Among the most upregulated genes, POSTN emerged as a key candidate and was further linked to adverse clinicopathologic characteristics. In an independent validation cohort (n = 120), higher POSTN expression was associated with inferior disease-free survival. Collectively, these results nominate POSTN as a potential prognostic biomarker and support ECM-centered and PI3K-AKT-related mechanisms as actionable biological features of lymph-node metastasis in HER2-positive breast cancer.

Subjects

MeSH terms (MEDLINE)

Breast NeoplasmsErb-b2 Receptor Tyrosine KinasesBiomarkers, TumorLymph NodesRNA-SeqCell Adhesion MoleculesHumansFemaleLymphatic MetastasisPeriostinPrognosis

Substances

Erb-b2 Receptor Tyrosine KinasesPeriostinBiomarkers, TumorPOSTN protein, humanERBB2 protein, humanCell Adhesion Molecules

Authors and institutions

  • Department of Breast Surgery, Boai Hospital of Zhongshan.
  • Department of Surgery, Boai Hospital of Zhongshan.
  • Department of Breast Surgery, Boai Hospital of Zhongshan; dryangjiehui33@163.com.

Cite

APA

Zhang, X., Xu, F., & Yang, J. (2026). RNA-seq Profiling of Draining and Metastatic Lymph Nodes in HER2-Positive Breast Cancer Identifies POSTN as a Prognostic Marker. Journal of Visualized Experiments. https://doi.org/10.3791/69570

Vancouver

Zhang X, Xu F, Yang J. RNA-seq Profiling of Draining and Metastatic Lymph Nodes in HER2-Positive Breast Cancer Identifies POSTN as a Prognostic Marker. Journal of Visualized Experiments. 2026. doi:10.3791/69570

BibTeX
@article{Zhang2026,
  author = {Zhang, Xiurong and Xu, Fei and Yang, Jiehui},
  title = {RNA-seq Profiling of Draining and Metastatic Lymph Nodes in HER2-Positive Breast Cancer Identifies POSTN as a Prognostic Marker},
  journal = {Journal of Visualized Experiments},
  year = {2026},
  doi = {10.3791/69570}
}
Start for free →